Sponsor content
192 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JAYPIRCA pirtobrutinib 100 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JAYPIRCA pirtobrutinib 50 mg film-coated tablet blister pack.
-
Prescription medicine decision summaryJaypirca (pirtobrutinib) is approved for the treatment of adults with chronic lymphocytic leukemia/small lymphocytic lymphoma who have been previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.
-
Jan-2026Prescription medicine evaluationActive ingredient: orforglipron calcium.
-
Dec-2025Prescription medicine evaluationActive ingredient: tirzepatide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 80 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 40 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 160 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 120 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation).